{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:12:50Z","timestamp":1783527170437,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:00:00Z","timestamp":1702080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["205320 179038"],"award-info":[{"award-number":["205320 179038"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-alcoholic fatty liver disease is rapidly emerging as the leading global cause of chronic liver disease. Efficient disease management requires low-cost, non-invasive techniques for diagnosing hepatic steatosis accurately. Here, we propose quantifying liver speed of sound (SoS) with computed ultrasound tomography in echo mode (CUTE), a recently developed ultrasound imaging modality adapted to clinical pulse-echo systems. CUTE reconstructs the spatial distribution of SoS by measuring local echo phase shifts when probing tissue at varying steering angles in transmission and reception.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this first-in-human phase II diagnostic study, we evaluated the liver of 22 healthy volunteers and 22 steatotic patients. We used conventional B-mode ultrasound images and controlled attenuation parameter (CAP) to diagnose the presence (CAP\u2265 280 dB\/m) or absence (CAP\u2009&lt;\u2009248 dB\/m) of steatosis in the liver. A fully integrated convex-probe CUTE implementation was developed on the ultrasound system to estimate liver SoS. We investigated its diagnostic value via the receiver operating characteristic (ROC) analysis and correlation to CAP measurements.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We show that liver CUTE-SoS estimates correlate strongly (<jats:italic>r<\/jats:italic>\u2009=\u2009\u22120.84, <jats:italic>p<\/jats:italic>\u2009=\u20098.27\u2009\u00d7\u200910<jats:sup>\u221213<\/jats:sup>) with CAP values and have 90.9% (95% confidence interval: 84\u2013100%) sensitivity and 95.5% (81\u2013100%) specificity for differentiating between normal and steatotic livers (area under the ROC curve: 0.93\u20131.0).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results demonstrate that liver CUTE-SoS is a promising quantitative biomarker for diagnosing liver steatosis. This is a necessary first step towards establishing CUTE as a new quantitative add-on to diagnostic ultrasound that can potentially be as versatile as conventional ultrasound imaging.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s43856-023-00409-3","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T05:01:37Z","timestamp":1702098097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["First-in-human diagnostic study of hepatic steatosis with computed ultrasound tomography in echo mode"],"prefix":"10.1038","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-8719","authenticated-orcid":false,"given":"Patrick","family":"St\u00e4hli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8262-0304","authenticated-orcid":false,"given":"Chiara","family":"Becchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-7900","authenticated-orcid":false,"given":"Naiara","family":"Korta Martiartu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-9016","authenticated-orcid":false,"given":"Annalisa","family":"Berzigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6741-9434","authenticated-orcid":false,"given":"Martin","family":"Frenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7695-9942","authenticated-orcid":false,"given":"Michael","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,9]]},"reference":[{"key":"409_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/liv.13299","volume":"37","author":"S Bellentani","year":"2017","unstructured":"Bellentani, S. The epidemiology of non-alcoholic fatty liver disease. Liver Int. 37, 81\u201384 (2017).","journal-title":"Liver Int."},{"key":"409_CR2","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.21827","volume":"46","author":"G Bedogni","year":"2007","unstructured":"Bedogni, G. et al. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology 46, 1387\u20131391 (2007).","journal-title":"Hepatology"},{"key":"409_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1055\/s-0028-1091983","volume":"28","author":"A Wieckowska","year":"2008","unstructured":"Wieckowska, A. & Feldstein, A. E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin. Liver Dis. 28, 386\u2013395 (2008).","journal-title":"Semin. Liver Dis."},{"key":"409_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363, 1341\u20131350 (2010).","journal-title":"N. Engl. J. Med."},{"key":"409_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14521","volume":"24","author":"MD Muthiah","year":"2022","unstructured":"Muthiah, M. D., Cheng Han, N. & Sanyal, A. J. A clinical overview of non-alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications\u2014What the non-specialist needs to know. Diabetes Obesity Metab 24, 3\u201314 (2022).","journal-title":"Diabetes Obesity Metab"},{"key":"409_CR6","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69, 1691\u20131705 (2020).","journal-title":"Gut"},{"key":"409_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti, A. et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update. J. Hepatol. 75, 659\u2013689 (2021).","journal-title":"J. Hepatol."},{"key":"409_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C. & Smith, A. D. Liver biopsy. Hepatology 49, 1017\u20131044 (2009).","journal-title":"Hepatology"},{"key":"409_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMra1610570","volume":"377","author":"EB Tapper","year":"2017","unstructured":"Tapper, E. B. & Lok, A. S.-F. Use of liver imaging and biopsy in clinical practice. N. Engl. J. Med. 377, 756\u2013768 (2017).","journal-title":"N. Engl. J. Med."},{"key":"409_CR10","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli, G. & Soares Monteiro, L. B. Ultrasound-based techniques for the diagnosis of liver steatosis. World J. Gastroenterol. 25, 6053\u20136062 (2019).","journal-title":"World J. Gastroenterol."},{"key":"409_CR11","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/j.ultrasmedbio.2021.06.002","volume":"47","author":"G Ferraioli","year":"2021","unstructured":"Ferraioli, G. et al. Quantification of liver fat content with ultrasound: a WFUMB position paper. Ultrasound Med. Biol. 47, 2803\u20132820 (2021).","journal-title":"Ultrasound Med. Biol."},{"key":"409_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0887-2171(95)90011-X","volume":"16","author":"WJ Zwiebel","year":"1995","unstructured":"Zwiebel, W. J. Sonographic diagnosis of diffuse liver disease. Semin. Ultrasound CT MRI 16, 8\u201315 (1995).","journal-title":"Semin. Ultrasound CT MRI"},{"key":"409_CR13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","volume":"51","author":"S Dasarathy","year":"2009","unstructured":"Dasarathy, S. et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J. Hepatol. 51, 1061\u20131067 (2009).","journal-title":"J. Hepatol."},{"key":"409_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1148\/radiol.10091790","volume":"256","author":"JR van Werven","year":"2010","unstructured":"van Werven, J. R. et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256, 159\u2013168 (2010).","journal-title":"Radiology"},{"key":"409_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/0301-5629(92)90116-R","volume":"18","author":"K Suzuki","year":"1992","unstructured":"Suzuki, K. et al. Dependence of ultrasonic attenuation of liver on pathologic fat and fibrosis: examination with experimental fatty liver and liver fibrosis models. Ultrasound Med. Biol. 18, 657\u2013666 (1992).","journal-title":"Ultrasound Med. Biol."},{"key":"409_CR16","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso, M. et al. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med. Biol. 36, 1825\u20131835 (2010).","journal-title":"Ultrasound Med. Biol."},{"key":"409_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ultrasmedbio.2015.08.008","volume":"42","author":"M Sasso","year":"2016","unstructured":"Sasso, M. et al. Liver steatosis assessed by controlled attenuation parameter (CAP) measured with the XL probe of the FibroScan: a pilot study assessing diagnostic accuracy. Ultrasound Med. Biol. 42, 92\u2013103 (2016).","journal-title":"Ultrasound Med. Biol."},{"key":"409_CR18","first-page":"w20077","volume":"149","author":"S Baumeler","year":"2019","unstructured":"Baumeler, S., Jochum, W., Neuweiler, J., Bergamin, I. & Semela, D. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience. Swiss Med. Weekly 149, w20077 (2019).","journal-title":"Swiss Med. Weekly"},{"key":"409_CR19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes, P. J. et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 156, 1717\u20131730 (2019).","journal-title":"Gastroenterology"},{"key":"409_CR20","doi-asserted-by":"publisher","first-page":"101547\u20131\u201315","DOI":"10.1016\/j.eclinm.2022.101547","volume":"51","author":"Y-t Cao","year":"2022","unstructured":"Cao, Y.-t, Xiang, L.-l, Zhang, Y.-j, Chen, Y. & Zhou, X.-q Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. eClinicalMedicine 51, 101547\u20131\u201315 (2022).","journal-title":"eClinicalMedicine"},{"key":"409_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","volume":"6","author":"D Petroff","year":"2021","unstructured":"Petroff, D. et al. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterol. Hepatol. 6, 185\u2013198 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"409_CR22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas, T. et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J. Hepatol. 66, 1022\u20131030 (2017).","journal-title":"J. Hepatol."},{"key":"409_CR23","doi-asserted-by":"crossref","first-page":"204062232110331","DOI":"10.1177\/20406223211033119","volume":"12","author":"CX Shao","year":"2021","unstructured":"Shao, C. X. et al. Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease. Therapeutic Adv. Chronic Dis. 12, 20406223211033119 (2021).","journal-title":"Therapeutic Adv. Chronic Dis."},{"key":"409_CR24","doi-asserted-by":"crossref","unstructured":"Duck, F. A. In Physical Properties of Tissues Ch 4 (ed. Duck, F. A.) 73\u2013135 (Academic Press, 1990).","DOI":"10.1016\/B978-0-12-222800-1.50008-5"},{"key":"409_CR25","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1088\/1361-6560\/aa6226","volume":"62","author":"M Imbault","year":"2017","unstructured":"Imbault, M. et al. Robust sound speed estimation for ultrasound-based hepatic steatosis assessment. Phys. Med. Biol. 62, 3582 (2017).","journal-title":"Phys. Med. Biol."},{"key":"409_CR26","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1007\/s00330-020-06885-8","volume":"30","author":"L Ruby","year":"2020","unstructured":"Ruby, L. et al. Speed of sound ultrasound: comparison with proton density fat fraction assessed with Dixon MRI for fat content quantification of the lower extremity. Eur. Radiol. 30, 5272 (2020).","journal-title":"Eur. Radiol."},{"key":"409_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1055\/a-0660-9465","volume":"40","author":"M Dioguardi Burgio","year":"2019","unstructured":"Dioguardi Burgio, M. et al. Ultrasonic adaptive sound speed estimation for the diagnosis and quantification of hepatic steatosis: a pilot study. Ultraschall Medizin-Eur. J. Ultrasound 40, 722\u2013733 (2019).","journal-title":"Ultraschall Medizin-Eur. J. Ultrasound"},{"key":"409_CR28","doi-asserted-by":"publisher","first-page":"215013","DOI":"10.1088\/1361-6560\/aae661","volume":"63","author":"M Imbault","year":"2018","unstructured":"Imbault, M. et al. Ultrasonic fat fraction quantification using in vivo adaptive sound speed estimation. Phys. Med. Biol. 63, 215013 (2018).","journal-title":"Phys. Med. Biol."},{"key":"409_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ultrasmedbio.2014.05.019","volume":"41","author":"M Jaeger","year":"2015","unstructured":"Jaeger, M. et al. Computed ultrasound tomography in echo mode for imaging speed of sound using pulse-echo sonography: proof of principle. Ultrasound Med. Biol. 41, 235\u2013250 (2015).","journal-title":"Ultrasound Med. Biol."},{"key":"409_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ultras.2015.06.003","volume":"62","author":"M Jaeger","year":"2015","unstructured":"Jaeger, M. & Frenz, M. Towards clinical computed ultrasound tomography in echo-mode: dynamic range artefact reduction. Ultrasonics 62, 299\u2013304 (2015).","journal-title":"Ultrasonics"},{"key":"409_CR31","doi-asserted-by":"publisher","first-page":"106168","DOI":"10.1016\/j.ultras.2020.106168","volume":"108","author":"P St\u00e4hli","year":"2020","unstructured":"St\u00e4hli, P., Kuriakose, M., Frenz, M. & Jaeger, M. Improved forward model for quantitative pulse-echo speed-of-sound imaging. Ultrasonics 108, 106168 (2020).","journal-title":"Ultrasonics"},{"key":"409_CR32","doi-asserted-by":"publisher","first-page":"215016","DOI":"10.1088\/1361-6560\/ac96c6","volume":"67","author":"M Jaeger","year":"2022","unstructured":"Jaeger, M. et al. Pulse-echo speed-of-sound imaging using convex probes. Phys. Med. Biol. 67, 215016 (2022).","journal-title":"Phys. Med. Biol."},{"key":"409_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1109\/TMI.2020.3029286","volume":"40","author":"P St\u00e4hli","year":"2020","unstructured":"St\u00e4hli, P., Frenz, M. & Jaeger, M. Bayesian approach for a robust speed-of-sound reconstruction using pulse-echo ultrasound. IEEE Trans. Med. Imaging 40, 457\u2013467 (2020).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"409_CR34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/bmj.330.7493.724","volume":"330","author":"C Gluud","year":"2005","unstructured":"Gluud, C. & Gluud, L. L. Evidence based diagnostics. BMJ 330, 724\u2013726 (2005).","journal-title":"BMJ"},{"key":"409_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cgh.2008.11.023","volume":"7","author":"SM Mazhar","year":"2009","unstructured":"Mazhar, S. M., Shiehmorteza, M. & Sirlin, C. B. Noninvasive assessment of hepatic steatosis. Clin. Gastroenterol. Hepatol. 7, 135\u2013140 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"409_CR36","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.7863\/jum.2010.29.11.1581","volume":"29","author":"B Boozari","year":"2010","unstructured":"Boozari, B. et al. Evaluation of sound speed for detection of liver fibrosis: prospective comparison with transient dynamic elastography and histology. J. Ultrasound. Med. 29, 1581\u20131588 (2010).","journal-title":"J. Ultrasound. Med."},{"key":"409_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A. et al. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42, 377\u2013381 (2009).","journal-title":"J. Biomed. Inform."},{"key":"409_CR38","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris, P. A. et al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inform. 95, 103208 (2019).","journal-title":"J. Biomed. Inform."},{"key":"409_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo, T. K. & Li, M. Y. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J. Chiropractic Med. 15, 155\u2013163 (2016).","journal-title":"J. Chiropractic Med."},{"key":"409_CR40","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ultrasmedbio.2015.03.007","volume":"41","author":"G Ferraioli","year":"2015","unstructured":"Ferraioli, G. et al. WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 3: Liver. Ultrasound Med. Biol. 41, 1161\u20131179 (2015).","journal-title":"Ultrasound Med. Biol."},{"key":"409_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/jimaging4120145","volume":"4","author":"M Kuriakose","year":"2018","unstructured":"Kuriakose, M., Muller, J.-W., St\u00e4hli, P., Frenz, M. & Jaeger, M. Receive beam-steering and clutter reduction for imaging the speed-of-sound inside the carotid artery. J. Imaging 4, 145 (2018).","journal-title":"J. Imaging"},{"key":"409_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-0961-9","volume":"19","author":"K Pu","year":"2019","unstructured":"Pu, K. et al. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis. BMC Gastroenterol. 19, 51 (2019).","journal-title":"BMC Gastroenterol."},{"key":"409_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/RLI.0000000000000553","volume":"54","author":"L Ruby","year":"2019","unstructured":"Ruby, L. et al. Breast cancer assessment with pulse-echo speed of sound ultrasound from intrinsic tissue reflections: proof-of-concept. Invest. Radiol. 54, 419\u2013427 (2019).","journal-title":"Invest. Radiol."},{"key":"409_CR44","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1158\/1940-6207.CAPR-19-0268","volume":"12","author":"R Natesan","year":"2019","unstructured":"Natesan, R., Wiskin, J., Lee, S. & Malik, B. H. Quantitative assessment of breast density: transmission ultrasound is comparable to mammography with tomosynthesis. Cancer Prevention Res. 12, 871\u2013876 (2019).","journal-title":"Cancer Prevention Res."},{"key":"409_CR45","doi-asserted-by":"crossref","unstructured":"Duric, N. et al. Using whole breast ultrasound tomography to improve breast cancer risk assessment: a novel risk factor based on the quantitative tissue property of sound speed. J. Clin. Med. 9 (2020).","DOI":"10.3390\/jcm9020367"},{"key":"409_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00330-018-5742-2","volume":"29","author":"SJ Sanabria","year":"2019","unstructured":"Sanabria, S. J. et al. Speed of sound ultrasound: a pilot study on a novel technique to identify sarcopenia in seniors. Eur. Radiol. 29, 3\u201312 (2019).","journal-title":"Eur. Radiol."},{"key":"409_CR47","doi-asserted-by":"crossref","unstructured":"Korta Martiartu, N. et al. Speed of sound and shear wave speed for calf soft tissue composition and nonlinearity assessment. Quantitative Imaging Med. Surg. 11, 4149\u20134161 (2021).","DOI":"10.21037\/qims-20-1321"},{"key":"409_CR48","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1088\/0031-9155\/60\/11\/4497","volume":"60","author":"M Jaeger","year":"2015","unstructured":"Jaeger, M., Robinson, E., Akar\u00e7ay, H. G. & Frenz, M. Full correction for spatially distributed speed-of-sound in echo ultrasound based on measuring aberration delays via transmit beam steering. Phys. Med. Biol. 60, 4497 (2015).","journal-title":"Phys. Med. Biol."},{"key":"409_CR49","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/0301-5629(86)90004-9","volume":"12","author":"C Sehgal","year":"1986","unstructured":"Sehgal, C., Brown, G., Bahn, R. & Greenleaf, J. Measurement and use of acoustic nonlinearity and sound speed to estimate composition of excised livers. Ultrasound Med. Biol. 12, 865\u2013874 (1986).","journal-title":"Ultrasound Med. Biol."},{"key":"409_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0301-5629(79)90083-8","volume":"5","author":"JC Bamber","year":"1979","unstructured":"Bamber, J. C. & Hill, C. Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature. Ultrasound Med. Biol. 5, 149\u2013157 (1979).","journal-title":"Ultrasound Med. Biol."},{"key":"409_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/016173468700900103","volume":"9","author":"T Lin","year":"1987","unstructured":"Lin, T., Ophir, J. & Potter, G. Correlations of sound speed with tissue constituents in normal and diffuse liver disease. Ultrason. Imaging 9, 29\u201340 (1987).","journal-title":"Ultrason. Imaging"},{"key":"409_CR52","doi-asserted-by":"publisher","first-page":"015007","DOI":"10.1088\/1361-6560\/ac4562","volume":"67","author":"AV Telichko","year":"2022","unstructured":"Telichko, A. V. et al. Noninvasive estimation of local speed of sound by pulse-echo ultrasound in a rat model of nonalcoholic fatty liver. Phys. Med. Biol. 67, 015007 (2022).","journal-title":"Phys. Med. Biol."},{"key":"409_CR53","first-page":"713\u2013722.e3","volume":"21","author":"M Lemoine","year":"2022","unstructured":"Lemoine, M. et al. Screening HIV patients at risk for NAFLD using MRI-PDFF and transient elastography: a European multicenter prospective study. Clin. Gastroenterol. Hepatol. 21, 713\u2013722.e3 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"409_CR54","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1002\/hep4.1948","volume":"6","author":"Z An","year":"2022","unstructured":"An, Z. et al. Relationship between controlled attenuated parameter and magnetic resonance imaging-proton density fat fraction for evaluating hepatic steatosis in patients with NAFLD. Hepatol. Commun. 6, 1975\u20131986 (2022).","journal-title":"Hepatol. Commun."},{"key":"409_CR55","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jceh.2021.10.003","volume":"12","author":"MS Kuchay","year":"2022","unstructured":"Kuchay, M. S. et al. Diagnostic accuracy and optimal cut-off of controlled attenuation parameter for the detection of hepatic steatosis in indian population. J. Clin. Exp. Hepatol. 12, 893\u2013898 (2022).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"409_CR56","doi-asserted-by":"publisher","unstructured":"Korta Martiartu, N. et al. Custom code and data for statistical analysis published in \u201cFirst-in-human diagnostic study of hepatic steatosis with computed ultrasound tomography in echo mode (CUTE)\u201d. https:\/\/doi.org\/10.48620\/269 (2023).","DOI":"10.48620\/269"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00409-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00409-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00409-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T16:05:12Z","timestamp":1702137912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-023-00409-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,9]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1038\/s43856-023-00409-3","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,9]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}